Search Results - "Apollonio, Giulia"

The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy by Fucà, Giovanni, Beninato, Teresa, Bini, Marta, Mazzeo, Laura, Di Guardo, Lorenza, Cimminiello, Carolina, Randon, Giovanni, Apollonio, Giulia, Bisogno, Ilaria, Del Vecchio, Marta, Lauria Pantano, Claudia, Di Nicola, Massimo, de Braud, Filippo, Del Vecchio, Michele

“…Background Since a non-negligible fraction of patients with metastatic melanoma does not experience long-term disease control, even with immunotherapy and…”
Get full text

Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic area by Taverna, Francesca, Alfieri, Salvatore, Romanò, Rebecca, Campanini, Giulia, Marceglia, Sara, Giardina, Federica, Mazzocchi, Arabella, Comoli, Patrizia, Gloghini, Annunziata, Quattrone, Pasquale, Bergamini, Cristiana, Apollonio, Giulia, Filippini, Daria Maria, Orlandi, Ester, Locati, Laura Deborah, Licitra, Lisa, Baldanti, Fausto, Bossi, Paolo

“…•Plasma EBV-DNA is a prognostic biomarker in NPC clinical management.•Multiple- (BamHI-W) vs single-copy gene (CE-marked) assays can detect…”
Get full text

Collecting ducts carcinoma: An orphan disease. Literature overview and future perspectives by Pagani, Filippo, Colecchia, Maurizio, Sepe, Pierangela, Apollonio, Giulia, Claps, Melanie, Verzoni, Elena, de Braud, Filippo, Procopio, Giuseppe

“…•Collecting ducts carcinoma (CDC) is a rare and aggressive disease.•Incurable when metastatic, chemotherapy has palliative role with poor responses.•Case…”
Get full text

Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients by Nichetti, Federico, Ligorio, Francesca, Zattarin, Emma, Signorelli, Diego, Prelaj, Arsela, Proto, Claudia, Galli, Giulia, Marra, Antonio, Apollonio, Giulia, Porcu, Luca, de Braud, Filippo, Lo Russo, Giuseppe, Ferrara, Roberto, Garassino, Marina Chiara

“…PD-1 pathway blockade has been shown to promote proatherogenic T-cell responses and destabilization of atherosclerotic plaques. Moreover, preclinical evidence…”
Get full text

SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis by Giugliano, Federica, Zucali, Paolo A., Galli, Giulia, Ballatore, Zelmira, Corti, Chiara, Aliaga, Pamela T., Uliano, Jacopo, Vivanet, Grazia, Curigliano, Giuseppe, Conforti, Fabio, Queirolo, Paola, Berardi, Rossana, Manglaviti, Sara, Apollonio, Giulia, Perrino, Matteo, Borea, Federica, D'Antonio, Federica, Garassino, Marina C., De Pas, Tommaso

“…International guidelines recommend severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine for patients with cancer. A substantial risk of…”
Get full text

High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitors by Manglaviti, Sara, Bini, Marta, Apollonio, Giulia, Zecca, Ernesto, Galli, Giulia, Sangaletti, Sabina, Labianca, Alice, Sottotetti, Elisa, Brambilla, Marta, Occhipinti, Mario, Proto, Claudia, Prelaj, Arsela, Signorelli, Diego, De Toma, Alessandro, Viscardi, Giuseppe, Beninato, Teresa, Mazzeo, Laura, Bottiglieri, Achille, Leporati, Rita, Fotia, Giuseppe, Ganzinelli, Monica, Portararo, Paola, Garassino, Marina Chiara, de Braud, Filippo G M, Lo Russo, Giuseppe, Torri, Valter, Ferrara, Roberto

“…Bone-targeted agents (BTA), such as denosumab (DN) and zoledronic acid (ZA), have historically reduced the risk of skeletal related events in cancer patients…”
Get full text

Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy by Zattarin, Emma, Manglaviti, Sara, Apollonio, Giulia, Beninato, Teresa, Mazzeo, Laura, Massa, Giacomo, Bottiglieri, Achille, Galli, Edoardogregorio, De Toma, Alessandro, Occhipinti, Mario, Brambilla, Marta, Ferrara, Roberto, Ganzinelli, Monica, Proto, Claudia, Garassino, Marina Chiara, de Braud, Filippo, Lo Russo, Giuseppe, Prelaj, Arsela

“…Clinical and laboratory biomarkers in patients with advanced non-small-cell lung cancer (aNSCLC) receiving chemo-immunotherapy (CIT) are still poorly explored…”
Get full text

Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies by Venema, Clasina M, Mammatas, Lemonitsa H, Schröder, Carolina P, van Kruchten, Michel, Apollonio, Giulia, Glaudemans, Andor W J M, Bongaerts, Alfons H H, Hoekstra, Otto S, Verheul, Henk M W, Boven, Epi, van der Vegt, Bert, de Vries, Erik F J, de Vries, Elisabeth G E, Boellaard, Ronald, Menke van der Houven van Oordt, Catharina W, Hospers, Geke A P

“…In addition to the well-known estrogen receptor (ER) and human epidermal growth factor receptor 2, the androgen receptor (AR) is also a potential drug target…”
Get full text

Safety and activity of radium-223 in metastatic castration-resistant prostate cancer: the experience of Istituto Nazionale dei Tumori by Raimondi, Alessandra, Sepe, Pierangela, Claps, Melanie, Maccauro, Marco, Aliberti, Gianluca, Pagani, Filippo, Apollonio, Giulia, Randon, Giovanni, Peverelli, Giorgia, Seregni, Ettore, Verzoni, Elena, Procopio, Giuseppe

“…Introduction: Therapeutic decision-making in metastatic castration-resistant prostate cancer (mCRPC) represents an open challenge. Radium-223 is approved for…”
Get full text

Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology by Manglaviti, Sara, Brambilla, Marta, Signorelli, Diego, Ferrara, Roberto, Lo Russo, Giuseppe, Proto, Claudia, Galli, Giulia, De Toma, Alessandro, Occhipinti, Mario, Viscardi, Giuseppe, Beninato, Teresa, Zattarin, Emma, Bini, Marta, Lobefaro, Riccardo, Massa, Giacomo, Bottiglieri, Achille, Apollonio, Giulia, Sottotetti, Elisa, Di Mauro, Rosa Maria, Trevisan, Benedetta, Ganzinelli, Monica, Fabbri, Alessandra, de Braud, Filippo G.M., Garassino, Marina Chiara, Prelaj, Arsela

“…•Efficacy of Immune-checkpoint inhibitors (ICIs) in non-small cell lung cancer with uncommon histology is an unmet need.•Our findings highlight no…”
Get full text

Hyperprogressive disease (HPD) in head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint inhibitors (ICI) by Alfieri, Salvatore, Ferrara, Roberto, Calareso, Giuseppina, Cavalieri, Stefano, Platini, Francesca, Mancinelli, Moela, Resteghini, Carlo, Orlandi, Ester, Iacovelli, Nicola Alessandro, Ferella, Letizia, Piazza, Cesare, Apollonio, Giulia, Galbiati, Donata, Bossi, Paolo, Bergamini, Cristiana, Locati, Laura Deborah, Licitra, Lisa F.

“…Abstract only 6029 Background: HPD was described in 9% of cancer patients (pts) treated in phase I trials, in 13.8% of advanced non-small cell lung cancer and…”
Get full text

The role of metastasectomy in advanced renal cell carcinoma by Apollonio, Giulia, Raimondi, Alessandra, Verzoni, Elena, Claps, Melanie, Sepe, Pierangela, Pagani, Filippo, Ratta, Raffaele, Montorsi, Francesco, De Braud, Filippo Guglielmo Maria, Procopio, Giuseppe

“…Introduction: So far, clinical experiences have proved metastasectomy as the only approach in the setting of metastatic renal cell carcinoma that may achieve…”
Get full text

Management of loco-regionally advanced squamous laryngeal cancer in elderly patients by Cavalieri, Stefano, Orlandi, Ester, Ivaldi, Eliana, Bergamini, Cristiana, Alfieri, Salvatore, Iacovelli, Nicola Alessandro, Ingargiola, Rossana, Resteghini, Carlo, Platini, Francesca, Apollonio, Giulia, Beninato, Teresa, Incandela, Fabiola, Fontanella, Walter, Bresciani, Lorenzo, Giannini, Lorenzo, Piazza, Cesare, Licitra, Lisa, Locati, Laura Deborah

“…Purpose To describe the management and outcomes of loco-regionally advanced (stages III-IV) laryngeal cancer (LRALC) in elderly patients. Methods Clinical…”
Get full text

Baseline and early change of neutrophil to lymphocyte ratio (bNLR and ΔNLR) as prognostic factors in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: Preliminary results of the Meet-URO 15 (I-BIO-REC) study by Rebuzzi, Sara Elena, Buti, Sebastiano, Galli, Luca, Procopio, Giuseppe, De Giorgi, Ugo, Baldessari, Cinzia, Massari, Francesco, Santini, Daniele, Cavo, Alessia, Banna, Giuseppe Luigi, Soraru', Mariella, Cortellini, Alessio, Messina, Marco, Martelli, Valentino, Damassi, Alessandra, Sbrana, Andrea, Apollonio, Giulia, Casadei, Chiara, Signori, Alessio, Fornarini, Giuseppe

“…Abstract only 752 Background: Biomarkers to select mRCC patients most likely to benefit to immune-checkpoint inhibitors are still needed. The ongoing…”
Get full text

Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study by Procopio, Giuseppe, Apollonio, Giulia, Cognetti, Francesco, Miceli, Rosalba, Milella, Michele, Mosca, Alessandra, Chiuri, Vincenzo Emanuele, Bearz, Alessandra, Morelli, Franco, Ortega, Cinzia, Atzori, Francesco, Donini, Maddalena, Ratta, Raffaele, Raimondi, Alessandra, Claps, Melanie, Martinetti, Antonia, Capitanio, Umberto, de Braud, Filippo G., Cappelletti, Vera, Verzoni, Elena

“…In selected metastatic renal cell carcinoma (mRCC) patients, radical metastasectomy followed by observation is a potential strategy. It is still to be defined…”
Get full text

15 First-line platinum-based chemotherapy combined with PD-1/PD-L1 inhibitors (ICI) prevents hyperprogression in non-small cell lung cancer (NSCLC) patients by reducing circulating immature neutrophils by Ferrara, Roberto, Russo, Giuseppe Lo, Jachetti, Elena, Calareso, Giuseppina, Proto, Claudia, Prelaj, Arsela, Galli, Giulia, Signorelli, Diego, Brambilla, Marta, Toma, Alessandro De, Occhipinti, Mario, Manglaviti, Sara, Apollonio, Giulia, Mazzeo, Laura, Ganzinelli, Monica, Martinetti, Antonia, Braud, Filippo De, Garassino, Marina, Colombo, Mario Paolo, Sangaletti, Sabina

“…Background Hyperprogression (HPD) has been described in ≃14–26% of NSCLC patients upon single-agent ICI 1 and has not been reported upon ICI and platinum-based…”
Get full text

Androgen receptor and estrogen receptor imaging in patients with metastatic breast cancer by Venema, Clasina Marieke, Mammatas, Lemonitsa H., van Kruchten, Michel, Apollonio, Giulia, Schroder, Carolina Pia, Glaudemans, Andor W. J. M., Hoekstra, Otto S., Verheul, Henk M.W., van der Vegt, Bert, De Vries, Erik F. J., De Vries, Elisabeth, Menke, Catharina Wilhelmina, Hospers, Geke

“…Abstract only…”
Get full text

Recommendations and Technical Aspects of 16α-[18F]Fluoro-17β-Estradiol PET to Image the Estrogen Receptor In Vivo: The Groningen Experience by Venema, Clasina M, Apollonio, Giulia, Hospers, Geke A.P, Schröder, Carolina P, Dierckx, Rudi A.J.O, de Vries, Erik F.J, Glaudemans, Andor W.J.M

“…ABSTRACTThe estrogen derivative 16α-F-fluoro-17β-estradiol (FES) is a PET tracer that has been used in a variety of preclinical and clinical studies to detect…”
Get full text